Merck Kgaa
(MRK.D.DX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 2,625,700 | 2,531,600 | 2,555,400 | 2,563,800 | 2,545,900 |
| Cost of Goods | 708,500 | 679,800 | 760,400 | 639,600 | 761,900 |
| Gross Profit | 1,917,200 | 1,851,800 | 1,795,000 | 1,924,200 | 1,784,000 |
| Operating Expenses | 1,625,600 | 1,518,500 | 1,806,500 | 1,394,600 | 1,659,400 |
| Operating Income | 291,600 | 333,300 | -11,500 | 529,600 | 124,600 |
| Other Income | -67,200 | -70,800 | -85,500 | -68,400 | -55,700 |
| Pre-tax Income | 224,400 | 262,500 | -97,000 | 461,200 | 68,900 |
| Income Tax | 85,400 | 32,600 | -12,900 | 117,000 | 23,400 |
| Net Income Continuous | 119,300 | 233,200 | -82,100 | 347,300 | 44,500 |
| Minority Interests | 19,700 | -3,300 | -1,900 | -3,100 | 1,000 |
| Net Income | $139,000 | $229,900 | $-84,000 | $344,200 | $45,500 |
| EPS Basic Total Ops | 0.31 | 0.52 | -0.20 | 0.79 | 0.11 |
| EPS Basic Continuous Ops | 0.31 | 0.52 | -0.20 | 0.79 | 0.11 |
| EPS Diluted Total Ops | 0.31 | 0.52 | -0.20 | 0.79 | 0.11 |
| EPS Diluted Continuous Ops | 0.31 | 0.52 | -0.20 | 0.79 | 0.11 |
| EBITDA(a) | $635,500 | $646,900 | $575,400 | $882,600 | $606,000 |